$ONCY insider trading
Over the last 12 months, Oncolytics Biotech insiders reported 12 buys totaling $363K and no sales across SEC Form 4 filings.
- Bought · 12m
- $363K 12 events
- Sold · 12m
- — 0 events
- Events · 12m
- 12 Form 4 filings, grouped
- Insiders · 12m
- 10 distinct reporters
- 10b5-1 share
- 0% of events, not dollars
All insider trades
Scroll the table sideways for price, value and marks.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Kelly JaredChief Executive Officer · O·D | ▲ Buy | 5,050 | $0.96 | $5K | +4.6% | — |
| Mar 11, 2026 | Parsons James T.D | ▲ Buy | 10,000 | $1.03 | $10K | +31.4% | — |
| Feb 12, 2026 | Seizinger Bernd R.D | ▲ Buy | 100,000 | $0.83 | $83K | +21.4% | 2 tranches |
| Feb 12, 2026 | Pisano WayneD | ▲ Buy | 30,000 | $0.84 | $25K | +6.5% | — |
| Feb 12, 2026 | Look KirkChief Financial Officer · O | ▲ Buy | 12,000 | $0.84 | $10K | +4.4% | — |
| Feb 12, 2026 | Kelly JaredChief Executive Officer · O·D | ▲ Buy | 35,100 | $0.84 | $30K | +47.5% | 2 tranches |
| Feb 12, 2026 | Heineman Thomas CharlesChief Medical Officer · O | ▲ Buy | 12,132 | $0.83 | $10K | +4.5% | — |
| Feb 12, 2026 | Hagerman AllisonVP, Product Development · O | ▲ Buy | 10,000 | $0.83 | $8K | +9.5% | — |
| Feb 12, 2026 | Brown Deborah MargaretD | ▲ Buy | 25,000 | $0.85 | $21K | +29.5% | — |
| Feb 12, 2026 | Andrews Patricia SD | ▲ Buy | 35,400 | $0.86 | $30K | +82.8% | — |
| Feb 11, 2026 | Aromando AndrewChief Business Officer · O | ▲ Buy | 29,600 | $0.86 | $25K | +116.1% | — |
| Jan 16, 2026 | Seizinger Bernd R.D | ▲ Buy | 100,000 | $1.04 | $104K | +27.2% | — |
Every $ONCY filing on this page is one API call away
The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Oncolytics Biotech filings can reach your inbox instead.
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ONCY feed.